149 related articles for article (PubMed ID: 18628145)
1. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies.
Clark AS; Vahdat LT
Support Cancer Ther; 2004 Jul; 1(4):213-8. PubMed ID: 18628145
[TBL] [Abstract][Full Text] [Related]
2. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Lipworth AD; Robert C; Zhu AX
Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
[TBL] [Abstract][Full Text] [Related]
3. Liposomal doxorubicin-related palmar-plantar erythrodysesthesia (hand-foot syndrome): a case report.
Ni C; Fang J; Qian H; Xu Q; Shen F
J Int Med Res; 2020 Dec; 48(12):300060520974854. PubMed ID: 33356712
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.
Harris CS; Wang D; Carulli A
J Oncol Pharm Pract; 2014 Feb; 20(1):73-80. PubMed ID: 23478198
[TBL] [Abstract][Full Text] [Related]
5. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.
Farr KP; Safwat A
Case Rep Oncol; 2011 Apr; 4(1):229-35. PubMed ID: 21537373
[TBL] [Abstract][Full Text] [Related]
6. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report.
Hu HP; Corkum MT; Perera F
Cureus; 2018 Dec; 10(12):e3704. PubMed ID: 30788193
[TBL] [Abstract][Full Text] [Related]
7. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Templeton AJ; Ribi K; Surber C; Sun H; Hsu Schmitz SF; Beyeler M; Dietrich D; Borner M; Winkler A; Müller A; von Rohr L; Winterhalder RC; Rochlitz C; von Moos R; Zaman K; Thürlimann BJ; Ruhstaller T;
Breast; 2014 Jun; 23(3):244-9. PubMed ID: 24656636
[TBL] [Abstract][Full Text] [Related]
8. Hand-foot syndrome induced by chemotherapy drug: Case series study and literature review.
Zaiem A; Hammamia SB; Aouinti I; Charfi O; Ladhari W; Kastalli S; Aidli SE; Lakhoua G
Indian J Pharmacol; 2022; 54(3):208-215. PubMed ID: 35848692
[TBL] [Abstract][Full Text] [Related]
9. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
10. A novel animal model of tegafur-induced hand-foot syndrome.
Takano-Mochizuki M; Nakajima K; Ishida T; Ohta E; Moriyama T; Asakura S
Toxicol Appl Pharmacol; 2024 Jun; 487():116977. PubMed ID: 38789014
[TBL] [Abstract][Full Text] [Related]
11. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
Law A; Dyson S; Anthony D
J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia.
Wahab A; Khakwani M; Ehsan H; Bellam N
Cureus; 2020 Nov; 12(11):e11507. PubMed ID: 33214972
[TBL] [Abstract][Full Text] [Related]
13. [Hand-foot syndrome (palmar-plantar erythrodysesthesia].
Salzberg M; Herrmann R
Schweiz Med Wochenschr; 2000 Oct; 130(40):1413-6. PubMed ID: 11059033
[TBL] [Abstract][Full Text] [Related]
14. Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient.
Whorton AE; Razzak AN; Jha P
Cureus; 2022 Jul; 14(7):e26891. PubMed ID: 35978746
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome--recall following different chemotherapy agents.
Hui YF; Giles FJ; Cortes JE
Invest New Drugs; 2002 Feb; 20(1):49-53. PubMed ID: 12003194
[TBL] [Abstract][Full Text] [Related]
16. Hand-foot syndrome induced changes of the palmar epidermal ridge configurations during and after treatment with capecitabine.
Hartung B; Thiel W; Ritz-Timme S; Häussinger D; Erhardt A
Leg Med (Tokyo); 2020 Apr; 45():101710. PubMed ID: 32353749
[TBL] [Abstract][Full Text] [Related]
17. Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
Fontenot AL; Furr WJ; Husan A; Khan MW
Cureus; 2021 Nov; 13(11):e20060. PubMed ID: 34993032
[TBL] [Abstract][Full Text] [Related]
18. Hand foot syndrome associated with standard dose cytarabine.
Sharma A; Baghmar S
Indian J Med Paediatr Oncol; 2013 Oct; 34(4):333. PubMed ID: 24604970
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine-Induced Genital Hand-Foot Syndrome Treated With Topical Tacrolimus.
Chan BL; Wang T
Cureus; 2024 Apr; 16(4):e57570. PubMed ID: 38707169
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
